Last reviewed · How we verify
NCT04696094
The Role of m6A RNA Modification in Moyamoya Disease
trial in Moyamoya Disease in 160 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Beijing Tiantan Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 1 January 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across China |
Conditions studied
- Moyamoya Disease — all drugs for Moyamoya Disease →
Sponsor
Beijing Tiantan Hospital
Who can join
Adults 4 to 60, any sex, with Moyamoya Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to detect the change of m6A RNA modification from peripheral blood of patients with moyamoya disease, and to assess the relationship between clinical characteristics.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of RNA methylation on Tumor angiogenesis and cancer progression.
Han M, Sun H, Zhou Q, Liu J, et al · · 2023 · cited 37× · PMID 38053093 · DOI 10.1186/s12943-023-01879-8
Verify or expand the search:
- PubMed search for NCT04696094
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Moyamoya Disease
Currently open trials in the same condition.
- NCT07304947 — Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery · NA · recruiting
- NCT07140731 — The Symani Restore Study · NA · recruiting
- NCT07144930 — Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments · NA · recruiting
- NCT07065409 — Treatment of Moyamoya Disease With iPSC-derived Exosomes · Phase 1 · recruiting
- NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting
Other Beijing Tiantan Hospital trials
Trials by the same sponsor.
- NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
- NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
- NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
- NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04696094 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
- Last refreshed: 17 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04696094.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing